Portland Global Advisors LLC Takes $2.10 Million Position in iShares Genomics Immunology and Healthcare ETF $IDNA

Portland Global Advisors LLC purchased a new position in shares of iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) during the second quarter, according to its most recent disclosure with the SEC. The institutional investor purchased 102,323 shares of the company’s stock, valued at approximately $2,099,000. Portland Global Advisors LLC owned 1.99% of iShares Genomics Immunology and Healthcare ETF as of its most recent filing with the SEC.

iShares Genomics Immunology and Healthcare ETF Stock Up 0.9%

NYSEARCA IDNA opened at $27.01 on Friday. iShares Genomics Immunology and Healthcare ETF has a 52 week low of $17.26 and a 52 week high of $27.65. The business has a 50 day moving average price of $25.33 and a 200-day moving average price of $22.88. The company has a market cap of $136.40 million, a price-to-earnings ratio of 14.76 and a beta of 1.07.

iShares Genomics Immunology and Healthcare ETF Profile

The iShares Genomics Immunology and Healthcare ETF (IDNA) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a market-cap-selected and -weighted index of global stocks involved in genomics, immunology, and bioengineering. IDNA was launched on Jun 11, 2019 and is managed by BlackRock.